Search Within

Advanced Practice Providers

Formats
  1. Meeting Abstract (754)
  2. Journal Article (589)
  3. Review (56)
  4. Book Section (39)
  5. Editorial (18)
  6. Research Letter (15)
  7. Miscellaneous (11)
  8. Conference Paper (4)
  9. Correspondence (4)
  10. Book Whole (1)
  11. Guidelines (1)
Groups
  1. Nursing (1172)
  2. Department of Medicine (704)
  3. Survivorship Research (530)
  4. Center for Hematologic Malignancies (363)
  5. Solid Tumor Oncology Division (350)
  6. Hematologic Malignancies, Division of (349)

More Groups

People
  1. Sergio Giralt (103)
  2. Miguel-Angel Perales (84)
  3. Gunjan Shah (73)
  4. Sean Devlin (71)
  5. Maria Palomba (69)
  6. Craig Sauter (63)

More People

Years
  1. 2026 (1)
  2. 2025 (78)
  3. 2024 (128)
  4. 2023 (97)
  5. 2022 (119)
  6. 2021 (108)

More Years

Publications
  1. Journal of Clinical Oncology (179)
  2. Oncology Nursing Forum (133)
  3. Blood (123)
  4. Biology of Blood and Marrow Transplantation (61)
  5. Clinical Journal of Oncology Nursing (50)
  6. Annals of Surgical Oncology (38)

More Publications

Publishers
  1. American Society of Clinical Oncology (202)
  2. Elsevier Inc. (200)
  3. Oncology Nursing Society (ONS) (188)
  4. American Society of Hematology (131)
  5. Lippincott Williams & Wilkins (103)
  6. Springer (72)

More Publishers

Results (1492)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Accuracy, sensitivity, and specificity of the LLIS and ULL27 in detecting breast cancer-related lymphedema
    Journal Article

    Coriddi, M.; Kim, L.; McGrath, L.; Encarnacion, E.; Brereton, N.; Shen, Y.; Barrio, A. V.; Mehrara, B.; Dayan, J. H.
    Annals of Surgical Oncology (2022)

    Fulltext@MSK | Save
  • Discharge prescribing of enteral opioids in opioid naìˆve patients following non-surgical intensive care: A retrospective cohort study
    Journal Article

    Tollinche, L. E.; Seier, K. P.; Yang, G.; Tan, K. S.; Tayban, Y. D.; Pastores, S. M.; Yeoh, C. B.; Karamchandani, K.
    Journal of Critical Care (2022)

    Fulltext@MSK | Save
  • A tale of two pulmonary artery catheters
    Journal Article

    Durack, J. C.; Chen, L. L.; Imran, S.; Halpern, N. A.
    Critical Care Nursing Quarterly (2022)

    Fulltext@MSK | Save
  • Cardio-oncology in the COVID-19 era
    Book Section

    Feldman, S.; Jang, K.; Smith, D.; Copeland-Halperin, R. S.
    In Steingart, R. M.; Liu, J. E. (Eds.) Atlas of Imaging in Cardio-Oncology: Case-Based Study Guide (2021)

    Fulltext@MSK | Save
  • Zanubrutinib, obinutuzumab, and venetoclax in chronic lymphocytic leukemia: Early MRD kinetics define a high-risk patient cohort with delayed bone marrow undetectable MRD and earlier post-treatment MRD recurrence
    Meeting Abstract

    Soumerai, J. D.; Mato, A. R.; Dogan, A.; Seshan, V.; Joffe, E.; Flaherty, K.; Carter, J.; Hochberg, E. P.; Barnes, J. A.; Hamilton, A.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Outcomes of chronic lymphocytic leukemia and Richter Transformation following discontinuation of noncovalent Bruton's Tyrosine Kinase inhibitors
    Meeting Abstract

    Thompson, M. C.; Coombs, C. C.; Roeker, L. E.; Pagel, J. M.; Jensen, J. L.; Battiato, K. E.; Fox, Y.; Meyer, K.; Bailey, N.; Rhodes, J. M.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Addressing a new challenge in chronic lymphocytic leukemia: Outcomes of therapies after exposure to both a covalent Bruton's Tyrosine Kinase Inhibitor and venetoclax
    Meeting Abstract

    Thompson, M. C.; Roeker, L. E.; Coombs, C. C.; Jensen, J. L.; Kamdar, M.; Skarbnik, A.; Pagel, J. M.; Bailey, N.; Pu, J. J.; Jacobs, R.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Timing and immune status after cellular therapies predict response to COVID-19 vaccines
    Meeting Abstract

    Tamari, R.; Politikos, I.; Knorr, D.; Vardhana, S.; Young, J.; Marcello, L.; Doddi, S.; Devlin, S. M.; Ramanathan, L.; Pessin, M. S.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • The intestinal microbiota correlates with response and toxicity after CAR T cell therapy in patients with B-cell malignancies
    Meeting Abstract

    Smith, M.; Dai, A.; Ghilardi, G.; Amelsberg, K.; Devlin, S. M.; Pajarillo, R.; Slingerland, J. B.; Beghi, S.; Herrera, P. S.; Giardina, P. A.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • A phase 2 study evaluating the addition of ublituximab and umbralisib (U2) to ibrutinib in patients with chronic lymphocytic leukemia (CLL): A minimal residual disease(MRD)-driven, time-limited approach
    Meeting Abstract

    Roeker, L. E.; Leslie, L. A.; Soumerai, J. D.; Falco, V.; Panton, G.; Zelenetz, A. D.; Falchi, L.; Park, J. H.; Pena-Velasquez, C.; Lebowitz, S.; more...
    Blood (2021)

    Fulltext@MSK | Save